학술논문
Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward.
Document Type
Academic Journal
Author
Lahariya C; Foundation for People-Centric Health Systems, New Delhi. Correspondence to: Dr Chandrakant Lahariya, B-2/173, First Floor, Safdarjung Enclave, New Delhi 110 029, India. c.lahariya@gmail.com.; Thakur A; Foundation for People-Centric Health Systems, New Delhi.; Dudeja N; Human Capital Lighthouse (Consulting) Pvt. Ltd., New Delhi.
Source
Publisher: Indian Pediatrics Country of Publication: India NLM ID: 2985062R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0974-7559 (Electronic) Linking ISSN: 00196061 NLM ISO Abbreviation: Indian Pediatr Subsets: MEDLINE
Subject
Language
English
Abstract
The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox virus and disease epidemiology to help clinicians, public health specialists, and policymakers to be prepared for any eventuality. This review summarises the monkeypox disease epidemiology, clinical features, therapies, vaccines and outlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, and immunocompromised hosts and this group need to be given special attention. The monkeypox disease outbreak (2022) in non-endemic countries should be used as an opportunity by India and other low and middle income countries to strengthen public health surveillance and health system capacity for outbreak and epidemic preparedness and response.